Treatment of Secondary Mitral Regurgitation in Heart Failure: A Shifting Paradigm in the Wake of the COAPT Trial
Secondary mitral regurgitation (MR) is common in patients with left heart dysfunction and it is associated with poor outcomes. Findings from the Cardiovascular Outcomes Assessment of the MitraClip Percutaneous Therapy for Heart Failure Patients with Functional Mitral Regurgitation (COAPT) trial, pub...
Main Authors: | Kelly H Schlendorf, Jared O’Leary, JoAnn Lindenfeld |
---|---|
Format: | Article |
Language: | English |
Published: |
Radcliffe Medical Media
2020-07-01
|
Series: | US Cardiology Review |
Online Access: | https://www.uscjournal.com/articleindex/usc.2020.05 |
Similar Items
-
Contemporary Management of Secondary Mitral Regurgitation
by: Kashish Goel, et al.
Published: (2020-05-01) -
Clinical Trial Perspective: Cost-effectiveness of Transcatheter Mitral Valve Repair Versus Medical Therapy in Patients with Heart Failure and Secondary Mitral Regurgitation. Results From the COAPT Trial
by: Suzanne J Baron
Published: (2020-08-01) -
Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.
by: Xavier Armoiry, et al.
Published: (2020-01-01) -
Multimodality Imaging in Secondary Mitral Regurgitation
by: Harish Sharma, et al.
Published: (2020-12-01) -
MitraClip for Secondary Mitral Regurgitation
by: Brian D. McCauley, MD, MPH, et al.
Published: (2021-03-01)